Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience

Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience

Abstract Purpose Despite recent advances in multimodal treatments, the prognosis of patients with glioblastoma multiforme (GBM) remains poor. The aim of this study was to evaluate the efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) co...

Full description

Bibliographic Details
Main Authors: Liangzhi Zhong, Lu Chen, Shengqing Lv, Qingrui Li, Guangpeng Chen, Wen Luo, Pu Zhou, Guanghui Li
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Radiation Oncology
Subjects:
Glioblastoma multiforme
Simultaneous integrated boost intensity-modulated radiotherapy
Temozolomide
Toxicity
Efficacy
Online Access:http://link.springer.com/article/10.1186/s13014-019-1305-1

Internet

http://link.springer.com/article/10.1186/s13014-019-1305-1

Similar Items